Steven M Friedman

Title: The Innovations of Steven M Friedman

Introduction

Steven M Friedman is a notable inventor based in Tenafly, NJ (US). He has made significant contributions to the field of immunology, particularly in the study of T-cell receptors. With a total of 4 patents, his work has advanced our understanding of autoimmune diseases, such as rheumatoid arthritis.

Latest Patents

Friedman's latest patents focus on conserved T-cell receptor sequences. He has isolated four unique transcripts from the β chain of the T cell receptor in T cells found in the synovial tissue of a patient with rheumatoid arthritis. Two of these transcripts were obtained from fresh synovial tissue, while the other two were derived from a T cell line originating from the synovial tissue. The sequences of these transcripts exhibit high homology, featuring a conserved amino acid sequence of IGQ_N in the highly diverse V-D junction. Additionally, the α chain and the antigenic specificity of the T cell line derived transcripts have also been characterized.

Career Highlights

Throughout his career, Steven M Friedman has worked with reputable organizations, including the New York Society for the Ruptured and Crippled and the New York Society for the Relief of the Ruptured and Crippled. His experience in these institutions has contributed to his expertise in the field of medical research and innovation.

Collaborations

Friedman has collaborated with notable colleagues, including Mary K Crow and Yixin Li. These partnerships have likely enriched his research and expanded the impact of his inventions.

Conclusion

Steven M Friedman is a distinguished inventor whose work in T-cell receptor research has led to important advancements in understanding autoimmune diseases. His contributions continue to influence the field of immunology and inspire future innovations.